PX4 Stock Chart & Stats
€204.00
€4.00(1.79%)
At close: 4:00 PM EDT
€204.00
€4.00(1.79%)
Day’s Range― - ―
52-Week Range€114.00 - €262.00
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
€6.24B
Enterprise Value€7.50B
Total Cash (Recent Filing)€314.05M
Total Debt (Recent Filing)€299.35M
Price to Earnings (P/E)37.9
Beta0.22
Next Earnings
Oct 28, 2026EPS Estimate
2.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.92
Shares Outstanding26,652,100
10 Day Avg. Volume9
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)2.66
Price to Sales (P/S)0.96
P/FCF Ratio25.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€278.37Price Target Upside36.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.92
Revenue Forecast (FY)€4.96B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthPlexus is converting customer demand into substantial near-term growth, with record quarterly revenue and guidance for more than 20% fiscal-year expansion. Sustained growth can improve scale, support operating leverage, and strengthen the company’s position across its targeted end markets.
Robust Program PipelineNew program wins and a record qualified funnel provide visible opportunities for future production revenue as programs ramp. This supports multi-quarter growth, broadens customer and end-market activity, and can improve factory utilization and earnings durability over the next several periods.
Conservative Balance SheetLow leverage gives Plexus financial flexibility to fund capacity, engineering investment, or working capital without excessive balance-sheet strain. Healthy returns on equity also indicate that the company is generating meaningful returns from its expanding asset base while keeping financial risk contained.
Bears Say
Weak Recent Cash ConversionPositive earnings are not currently translating into cash at a consistent rate, reducing internally generated funds available for investment and shareholder returns. The decline in free cash flow and historically volatile cash outcomes make financial performance more sensitive to working-capital and investment swings.
Component Tightness Pressures CashPreplacing inventory can help Plexus protect customer production schedules, but it ties up cash before related revenue is realized. If component constraints persist, higher inventory and working-capital requirements could continue to weigh on cash conversion and limit near-term financial flexibility.
Modest Margin BasePlexus’s relatively modest margins leave less protection against unfavorable program mix, pricing pressure, or utilization changes. Even with recent improvement, small operational disruptions can have an outsized effect on profit generation, making sustained execution important to preserve earnings quality.
Plexus News
PX4 FAQ
What was Plexus’s price range in the past 12 months?
Plexus lowest stock price was €114.00 and its highest was €262.00 in the past 12 months.
What is Plexus’s market cap?
Plexus’s market cap is €6.24B.
When is Plexus’s upcoming earnings report date?
Plexus’s upcoming earnings report date is Oct 28, 2026 which is in 15 days.
How were Plexus’s earnings last quarter?
Plexus released its earnings results on Jul 29, 2026. The company reported €2.069 earnings per share for the quarter, beating the consensus estimate of €1.901 by €0.168.
Is Plexus overvalued?
According to Wall Street analysts Plexus’s price is currently Undervalued.
Does Plexus pay dividends?
Plexus does not currently pay dividends.
What is Plexus’s EPS estimate?
Plexus’s EPS estimate is 2.28.
How many shares outstanding does Plexus have?
Plexus has 26,652,100 shares outstanding.
What happened to Plexus’s price movement after its last earnings report?
Plexus reported an EPS of €2.069 in its last earnings report, beating expectations of €1.901. Following the earnings report the stock price went down -4.587%.
Which hedge fund is a major shareholder of Plexus?
Currently, no hedge funds are holding shares in DE:PX4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Plexus Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€278.37 (36.46% Upside)
€278.37 (36.46% Upside)
Blogger Sentiment
Bullish
DE:PX4 Sentiment 60%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.29%
12-Months-Change
Fundamentals
Return on Equity
12.46%
Trailing 12-Months
Asset Growth
17.00%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Plexus
Operating globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions, Plexus Corp. and its subsidiaries specialize in delivering advanced electronic manufacturing solutions. The company provides a comprehensive range of services, including design and development, efficient supply chain management, support for new product introductions, and core manufacturing capabilities, alongside essential aftermarket services. These offerings are tailored for businesses in key market segments such as healthcare/life sciences, industrial/commercial, aerospace/defense, and communications. Established in 1979, Plexus Corp. maintains its corporate headquarters in Neenah, Wisconsin.
PX4 Company Deck
PX4 Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall: Plexus reported record quarterly revenue (+28% YoY), delivered improved operating margin and an EPS beat, announced substantial new program wins and a record $4.5 billion funnel, and showed marked working capital improvements (62-day cash cycle, 14.9% ROIC). Management provided bullish guidance for fiscal Q4 and fiscal 2026 (revenue growth >20%) and signaled potential for continued margin expansion and strong free cash flow in fiscal 2027. Key near-term concerns include supply-chain-driven inventory preplacement that pressures working capital (leading to a Q4 free cash flow breakeven/slight usage), rising interest/non-operating expense, and expected moderation in Healthcare growth and incomplete recovery in commercial aerospace. Overall, the positive operational momentum, sizable wins funnel and improved capital efficiency outweigh the manageable near-term headwinds.View all DE:PX4 earnings summariesPX4 Stock 12 Month Forecast
Average Price Target
€278.37
▲(36.46% Upside)